Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphoma.

Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphoma. Blood Adv. 2021 03 23; 5(6):1648-1659.

View in: PubMed

subject areas

Antineoplastic Combined Chemotherapy Protocols
Hematopoietic Stem Cell Transplantation
Hodgkin Disease
Humans
Neoplasm Recurrence, Local
Retrospective Studies
Transplantation, Autologous

authors with profiles

Justin Kline